MBOT
Price
$0.98
Change
+$0.01 (+1.03%)
Updated
Oct 11 closing price
20 days until earnings call
NVCR
Price
$15.75
Change
+$0.88 (+5.92%)
Updated
Oct 11 closing price
18 days until earnings call
Ad is loading...

MBOT vs NVCR

Header iconMBOT vs NVCR Comparison
Open Charts MBOT vs NVCRBanner chart's image
Microbot Medical
Price$0.98
Change+$0.01 (+1.03%)
Volume$86.08K
CapitalizationN/A
NovoCure
Price$15.75
Change+$0.88 (+5.92%)
Volume$722.56K
CapitalizationN/A
View a ticker or compare two or three
MBOT vs NVCR Comparison Chart
Loading...
MBOT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
MBOT vs. NVCR commentary
Oct 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MBOT is a Hold and NVCR is a StrongBuy.

COMPARISON
Comparison
Oct 13, 2024
Stock price -- (MBOT: $0.98 vs. NVCR: $15.75)
Brand notoriety: MBOT and NVCR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MBOT: 77% vs. NVCR: 80%
Market capitalization -- MBOT: $18.57M vs. NVCR: $1.66B
MBOT [@Medical Specialties] is valued at $18.57M. NVCR’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MBOT’s FA Score shows that 0 FA rating(s) are green whileNVCR’s FA Score has 1 green FA rating(s).

  • MBOT’s FA Score: 0 green, 5 red.
  • NVCR’s FA Score: 1 green, 4 red.
According to our system of comparison, both MBOT and NVCR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MBOT’s TA Score shows that 6 TA indicator(s) are bullish while NVCR’s TA Score has 5 bullish TA indicator(s).

  • MBOT’s TA Score: 6 bullish, 4 bearish.
  • NVCR’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both MBOT and NVCR are a good buy in the short-term.

Price Growth

MBOT (@Medical Specialties) experienced а +9.16% price change this week, while NVCR (@Medical Specialties) price change was +7.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -2.01%. For the same industry, the average monthly price growth was +3.93%, and the average quarterly price growth was -2.96%.

Reported Earning Dates

MBOT is expected to report earnings on Nov 01, 2024.

NVCR is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Medical Specialties (-2.01% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVCR($1.66B) has a higher market cap than MBOT($18.6M). NVCR YTD gains are higher at: 5.492 vs. MBOT (-40.024). MBOT has higher annual earnings (EBITDA): -10.75M vs. NVCR (-177.45M). NVCR has more cash in the bank: 911M vs. MBOT (8.15M). MBOT has less debt than NVCR: MBOT (245K) vs NVCR (596M). NVCR has higher revenues than MBOT: NVCR (509M) vs MBOT (0).
MBOTNVCRMBOT / NVCR
Capitalization18.6M1.66B1%
EBITDA-10.75M-177.45M6%
Gain YTD-40.0245.492-729%
P/E RatioN/AN/A-
Revenue0509M-
Total Cash8.15M911M1%
Total Debt245K596M0%
FUNDAMENTALS RATINGS
MBOT vs NVCR: Fundamental Ratings
MBOT
NVCR
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9896
PRICE GROWTH RATING
1..100
6062
P/E GROWTH RATING
1..100
10012
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MBOT's Valuation (45) in the Biotechnology industry is somewhat better than the same rating for NVCR (100) in the Medical Specialties industry. This means that MBOT’s stock grew somewhat faster than NVCR’s over the last 12 months.

MBOT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as NVCR (100) in the Medical Specialties industry. This means that MBOT’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's SMR Rating (96) in the Medical Specialties industry is in the same range as MBOT (98) in the Biotechnology industry. This means that NVCR’s stock grew similarly to MBOT’s over the last 12 months.

MBOT's Price Growth Rating (60) in the Biotechnology industry is in the same range as NVCR (62) in the Medical Specialties industry. This means that MBOT’s stock grew similarly to NVCR’s over the last 12 months.

NVCR's P/E Growth Rating (12) in the Medical Specialties industry is significantly better than the same rating for MBOT (100) in the Biotechnology industry. This means that NVCR’s stock grew significantly faster than MBOT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MBOTNVCR
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 5 days ago
71%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 16 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
MBOT
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NVCR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X62445.0900002170.586000
+3.60%
Bitcoin cryptocurrency
SPY579.583.45
+0.60%
SPDR® S&P 500® ETF Trust
GME20.83-0.08
-0.38%
GameStop Corp
AAPL227.55-1.49
-0.65%
Apple
TSLA217.80-20.97
-8.78%
Tesla

MBOT and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBOT has been loosely correlated with MASS. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MBOT jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBOT
1D Price
Change %
MBOT100%
+0.90%
MASS - MBOT
36%
Loosely correlated
+4.52%
NVCR - MBOT
34%
Loosely correlated
+5.92%
CORBF - MBOT
33%
Loosely correlated
-28.57%
OTCFF - MBOT
29%
Poorly correlated
-11.29%
SRDX - MBOT
28%
Poorly correlated
-0.23%
More

NVCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVCR has been loosely correlated with MASS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if NVCR jumps, then MASS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVCR
1D Price
Change %
NVCR100%
+5.92%
MASS - NVCR
49%
Loosely correlated
+4.52%
GH - NVCR
45%
Loosely correlated
+3.83%
VCYT - NVCR
43%
Loosely correlated
+5.42%
TWST - NVCR
43%
Loosely correlated
+6.77%
KIDS - NVCR
43%
Loosely correlated
+1.61%
More